Friday, February 19, 2021Volume 2, Issue 14 “The principles of a free constitution are irrecoverably lost, when the legislative power is nominated by the executive.” — Edward...
Pfizer Inc. and BioNTech SE started an international study with 4,000 volunteers to evaluate the safety and effectiveness of their COVID-19 vaccine in healthy pregnant women.
Roku posted a profit for the fourth quarter, surprising investors. Additionally, the company surpassed 50 million active accounts, ending 4Q with 51.2 million active accounts. The...
A transcript of The Conversation Weekly podcast episode #3.
A new study shows the South African coronavirus variant may cut the effectiveness of Pfizer/BioNTech’s vaccine by around two thirds
COVID-19 has increased demands on informal carers and severely increased demands on their mental, physical and financial wellbeing, The post COVID-19 increased demands on carers’ wellbeing,...
The World Health Organization listed AstraZeneca’s Covid-19 vaccine for emergency use, widening access in the developing world, while sources said the EU is in talks with...
More than 15 million people in the UK have had their first coronavirus vaccine, described as a ‘significant The post UK government mulls lockdown review as...
In previous posts, I covered the latest data for weekly Covid19 pandemic dynamics for:Global data and trends: https://trueeconomics.blogspot.com/2021/02/14221-covid19-update-worldwide-data.html;European & EU27 data and trends: https://trueeconomics.b
We can help vaccines keep up with the mutating coronavirus by doubling down on preventive measures.
The world's most advanced economies will incur half the total costs associated with a failure to vaccinate poorer nations, which could exceed $4 trillion if only...
We can help vaccines keep up with the mutating coronavirus by doubling down on preventive measures.
How the UK came to be the world leader in sequencing SARS-CoV-2, in the words of the person who made it all happen.
How the UK came to be the world leader in sequencing SARS-CoV-2, in the words of the person who made it all happen.
Visualizing Global Attitudes Towards The COVID-19 Vaccines To vaccinate, or not to vaccinate? That is the question. In order to achieve herd immunity against COVID-19, some...
Biden Mulls Domestic Travel Restrictions Despite Improving COVID Backdrop Despite headlines discussing COVID 'plateaus' and 'dramatic declines' in the United States, the Biden administration is mulling...
The arrival of COVID-19 vaccines has raised hope for an end to the pandemic. Hopefully that's true, but there are variables. Here are some factors that...
Brazilian researchers applied an examination protocol based on an analysis of 12 lung regions to 180 severe patients and found that the higher the lung ultrasound...
The impact from COVID-19 on Emerging Markets has, in many ways, been even more severe than the developed world. Many middle and low income countries have...
McIntyre Partnerships commentary for the fourth quarter ended December 2020, discussing discussing their new positions in Marcus Corp (NYSE:MCS) and Corporacion America Airports SA (NYSE:CAAP). Q4...
CNBC Transcript: Johnson & Johnson Chairman & CEO Alex Gorsky speaks with Meg Tirrell live during CNBC’s Healthy Returns Spotlight today on the company’s one-shot coronavirus...
Credit: Images by Jungsik Noh via GitHub DALLAS – Feb. 8, 2021 – World health experts have long suspected that the incidence of COVID-19 has been...
The new coronavirus mutant strains are playing havoc with the already approved Covid-19 vaccines. The latest data shows AstraZeneca's (AZN) vaccine, AZD1222 is ineffective against the...
Credit: Archive of the History of Medicine, University of Zurich In the event of a pandemic, delayed reactions and a decentralized approach by the authorities at...
It can be hard sometimes to motivate yourself to work hard day in and day out. We do it for many reasons, whether that’s to pay...
InEvent, a startup powering virtual and hybrid events, is announcing that it has raised $2 million in seed funding from Storm Ventures. That’s just tiny fraction...
Sinovac Biotech’s Covid-19 vaccine was approved for use by the general public by China’s medical products regulator.
South Africa delayed the distribution of the AstraZeneca-University of Oxford Covid-19 vaccine after data suggested it “provides minimal protection” against mild disease from the South African...
By Alejandro Werner, Anna Ivanova, and Takuji Komatsuzaki Español Latin America and Caribbean economies managed to bounce back from COVID-19’s initial economic devastation earlier in 2020....
China’s national regulator has approved Sinovac Biotech’s COVID-19 vaccine for use by the general public. This is the The post China approves Sinovac’s coronavirus vaccine appeared...